Vestibular schwannoma: the slow benign tumor on the hearing nerve, the one-sided hearing loss, and how to choose between watching and treating
Last updated September 3, 2026.
A vestibular schwannoma, the old name is acoustic neuroma, is a slow-growing, non-cancerous tumor of the nerve sheath around the nerve for balance and hearing between the inner ear and the brain. It is benign, it does not spread, and it grows slowly, often over years, which is why the first sign is usually so quiet: hearing fading on one side, or tinnitus in one ear, sometimes with unsteadiness. The diagnosis comes from an MRI, prompted by exactly that one-sided picture, which is why one-sided hearing loss or one-sided tinnitus always deserves a referral even when it seems small. The management is a real three-way choice, and for many small tumors the first choice is doing nothing but scanning: watch-and-wait with serial MRIs, because a large share of these tumors grow so slowly they never need treatment. When treatment is needed, for growth, size, or symptoms, the options are keyhole radiosurgery, a single tightly-targeted dose of radiation that stops growth in most, or microsurgery to remove the tumor, and the choice between them turns on size, age, hearing, and preference. The worth-knowing parts: the hearing on the affected side often cannot be fully restored regardless of the path, and saying so early is kinder than the alternative; the facial nerve, which moves the face, runs beside the tumor and its protection drives many of the decisions; very rarely, tumors on both sides point to the inherited condition NF2, which is why both ears get looked at; and the balance problems usually improve as the brain compensates, with physiotherapy helping it along.
What does it look like?
Hearing fading on one side, often first noticed on the phone, tinnitus in one ear, and unsteadiness rather than true spinning. Larger tumors can add facial numbness, headaches, and pressure symptoms, but the modern story is usually the quiet one: a one-sided hearing change that finally earns an MRI. A good share are found by chance on scans done for something else entirely.
Why does it happen?
The Schwann cells that wrap the hearing and balance nerve acquire a growth change and multiply slowly into a benign knot. For the vast majority it is a one-off with no known cause, no link to phones or noise, and no family pattern. Tumors on both sides are the rare exception and point to the inherited condition neurofibromatosis type 2, which is why both ears and the family history get checked.
How is it treated?
- Many are watched, not treated. Small tumors often grow so slowly that serial MRI scanning is the whole plan, and a large share never need anything more.
- Radiosurgery stops growth in most. A single tightly-targeted radiation dose, no incision, is the commonest active treatment for tumors of small to medium size, trading removal for control.
- Microsurgery removes it when removal is right. For larger tumors or those pressing on the brainstem, surgery in an experienced center is the answer, and the facial nerve's protection drives the planning.
- The hearing gets its own plan. The affected ear's hearing often cannot be fully restored by any path, so hearing rehabilitation, including devices that route sound to the good ear, is part of the package, and the balance is retrained with physiotherapy.
When does it need prompt advice?
A new weakness or droop of the face, a sudden further drop in hearing, severe worsening headache with vomiting, or new double vision earns prompt advice. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
How can just watching a brain tumor be a real option?
Because the evidence says so, and because of what this particular tumor is. A vestibular schwannoma is benign, not cancer, no spreading, no invading, and it grows, when it grows at all, at millimeters per year. The data on small tumors like yours is unusually clear: a large share grow so slowly they never need treatment, and studies comparing early treatment against careful scanning find no advantage in rushing, only the treatment's risks spent on a tumor that might never have moved. Watching is also not ignoring: the MRI schedule is tight at first, the intervals stretch as the tumor proves its temperament, and if the scans ever show meaningful growth, the full menu of treatments is still there. You are not doing nothing; you are running the option that costs nothing until it is needed.
How do I choose between watching, radiosurgery, and surgery?
By understanding that the three paths converge on control, so the choice is when to spend each option's cost, not right versus wrong. Watching spends nothing and keeps every option open, at the price of living with scans and the idea of it. Radiosurgery, a single tightly-targeted radiation dose with no incision, stops growth in most small-to-medium tumors, at the price of a small risk to the hearing and the facial nerve and years of follow-up scans afterward. Surgery removes the tumor outright, at the price of an operation, a recovery, and a somewhat higher risk to the facial nerve, which is why it is usually reserved for larger tumors. The questions that settle it: how much hearing is there to protect, how do you personally weigh a small risk now against a possible treatment later, and which option lets you sleep. There is no wrong answer, only the one that fits you.
My wife wants it out immediately. Is she wrong?
Her instinct is the understandable human one, and it deserves respect as the anxiety talking rather than dismissal as being wrong. To most people the words brain tumor admit exactly one response, out, now, and her love for you is speaking the language everyone speaks before they read the evidence. The evidence, though, is on the side of the pause: an 11mm benign tumor, with watching carrying no survival penalty and early treatment carrying real if small costs, is precisely the situation medicine designed watch-and-wait for. The way through it as a couple: bring her to the appointment, let the surgeon answer her directly, and frame the choice the way the evidence frames it, not treat-versus-ignore but now-versus-when-needed. Most families find the fear settles once the specialist explains the tumor's actual temperament, and once the first follow-up scan shows it sitting still.
Will I get my hearing back in that ear?
The honest answer, kinder said early: the hearing on the affected side often cannot be fully restored by any of the three paths, because the tumor grows from the hearing nerve itself and the damage is usually done by the nerve's slow compression, not by anything treatment can reverse. What treatment protects is the hearing that remains, and acting before it deteriorates further is one of the few arguments for not waiting too long once growth is shown. The practical side is better than most people expect: hearing rehabilitation for one-sided loss is a well-developed field, including devices that route sound from the deaf side to the good ear, and most people adapt far better than they fear, the phone changes ears, the seating at dinner changes sides, and life fills the gap. The balance, unlike the hearing, usually improves substantially as the brain compensates.
What are the risks of radiosurgery and of surgery?
Both are safe in experienced hands and both carry the same two nerves at stake, the hearing nerve and the facial nerve, which is the one that moves the face and the one everyone cares about most. Radiosurgery: no incision, done in a day, stops the tumor's growth in the great majority, with a small risk over the following years to the hearing on that side and a very small risk to the facial nerve, plus the need for years of follow-up scans because the tumor is controlled rather than gone. Surgery: an operation and a recovery measured in weeks, the tumor physically removed, with the facial nerve outcome depending heavily on tumor size and the team's volume, which is why the center's experience is a fair question to ask directly. In both cases the risks concentrate on the nerves, and in both cases the numbers are best quoted by your own team for your own tumor size.
Will it keep growing, and how long do the scans go on?
Nobody can promise an individual tumor's future, and the scan schedule exists precisely because of that. The statistics are on your side: a large share of small vestibular schwannomas grow so slowly they never need treatment, some stop growing entirely, and a minority even shrink. But the schedule is the honest answer to the uncertainty: scans annually at first, then stretching as the tumor proves its temperament, and continuing long-term because late growth, while uncommon, is exactly what the surveillance is there to catch. If the scans show sustained growth, the treatment conversation reopens with all options still on the table. The way most people come to hold it: the first stable scan quiets the fear a little, the second a little more, and by the third the tumor has usually shrunk from a monster to a line in the calendar.